Adma Biologics Inc. logo

Adma Biologics Inc. (ADMA)

Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
9. 33
-0.06
-0.639%
$
2.18B Market Cap
- P/E Ratio
- Div Yield
1.76M Volume
-0.02 Eps
$ 9.39
Previous Close
Add Transaction
Day Range
9.29 9.5
Year Range
7.21 20.46
Want to track ADMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
New Strong Buy Stocks for March 25th

New Strong Buy Stocks for March 25th

EQT, BCBP, FIX, PAAS and ADMA have been added to the Zacks Rank #1 (Strong Buy) List on March 25, 2026.

Zacks | 5 months ago
New Strong Buy Stocks for March 23rd

New Strong Buy Stocks for March 23rd

LCUT, EFXT, MGA, ADMA and JLL have been added to the Zacks Rank #1 (Strong Buy) List on March 23, 2026.

Zacks | 5 months ago
Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors

Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors

In the closing of the recent trading day, Adma Biologics (ADMA) stood at $15.02, denoting a +1.01% move from the preceding trading day.

Zacks | 5 months ago
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?

Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Zacks | 5 months ago
ADMA Biologics Inc $ADMA Shares Bought by B Group Inc.

ADMA Biologics Inc $ADMA Shares Bought by B Group Inc.

B Group Inc. grew its stake in ADMA Biologics Inc (NASDAQ: ADMA) by 4.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,412,542 shares of the biotechnology company's stock after purchasing an additional 95,000 shares during the quarter. ADMA Biologics

Defenseworld | 5 months ago
Why the Market Dipped But Adma Biologics (ADMA) Gained Today

Why the Market Dipped But Adma Biologics (ADMA) Gained Today

Adma Biologics (ADMA) concluded the recent trading session at $15.15, signifying a +1.03% move from its prior day's close.

Zacks | 5 months ago
4 Biotech Stocks to Watch for Potential Upside in 2026

4 Biotech Stocks to Watch for Potential Upside in 2026

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position TERN, ADMA, ANIP and LQDA in this volatile sector.

Zacks | 5 months ago
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note

Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note

Adma Biologics (ADMA) reached $14.99 at the closing of the latest trading day, reflecting a -4.34% change compared to its last close.

Zacks | 5 months ago
Best Momentum Stocks to Buy for March 12th

Best Momentum Stocks to Buy for March 12th

ADMA, RELY and HSY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 12th, 2026.

Zacks | 5 months ago
New Strong Buy Stocks for March 12th

New Strong Buy Stocks for March 12th

AEO, RELY, ADMA, HSY and HTBK have been added to the Zacks Rank #1 (Strong Buy) List on March 12th, 2026.

Zacks | 5 months ago
Adma Biologics (ADMA) Upgraded to Strong Buy: Here's Why

Adma Biologics (ADMA) Upgraded to Strong Buy: Here's Why

Adma Biologics (ADMA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 6 months ago
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?

Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks | 6 months ago
Loading...
Load More